Stock Cash Premium: Sun Pharma’s arm Taro plans shares repurchase worth US$ 250mn

For Stock Cash Premium www.marketmagnify.com/stock-cash-power.php

Taro Pharmaceutical Industries reportedly said that its board of directors has approved a $250-mn share repurchase of its ordinary shares.

Repurchases may be made from time to time at the company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its stock, and general market conditions, the company reportedly said.

Sun Pharmaceuticals Industries Ltd ended at Rs. 836.65, down by Rs. 7.25 or 0.86% from its previous closing of Rs. 843.9 on the BSE.

The stock traded below its 200 DMA.